HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacob J Bleesing Selected Research

Melphalan (Alkeran)

11/2016A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacob J Bleesing Research Topics

Disease

3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 02/2014
1Bronchiolitis Obliterans Syndrome
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Activated PI3K-delta Syndrome
01/2022
1Neutropenia
01/2022
1Cytopenia
01/2021
1Neoplasms (Cancer)
11/2017
1Tetanus
11/2017
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2016
1Chronic Granulomatous Disease
11/2016

Drug/Important Bio-Agent (IBA)

3Alemtuzumab (Campath)FDA Link
12/2016 - 02/2014
2SteroidsIBA
12/2016 - 02/2014
1Alanine Transaminase (SGPT)IBA
01/2022
1ruxolitinibIBA
01/2022
1daratumumabIBA
01/2021
1MaravirocFDA Link
01/2020
1AntigensIBA
11/2017
1Melphalan (Alkeran)FDA LinkGeneric
11/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2016
1Busulfan (Busulfex)FDA Link
11/2016
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
11/2016
1fludarabineIBA
11/2016

Therapy/Procedure

2Transplantation
12/2016 - 11/2016
1Cell Transplantation
01/2022
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2017
1Hematopoietic Stem Cell Transplantation
12/2016